Novo Nordisk sues Eli Lilly over Zepbound and Mounjaro advertisements

Danish pharmaceutical giant Novo Nordisk announced that it has filed a lawsuit in a U.S.

federal court against its American rival Eli Lilly. The lawsuit is based on the allegation that Eli Lilly's advertising campaigns regarding the obesity drug Zepbound and the diabetes treatment Mounjaro are…